HCPLive Network


Holistic Exercise Program Seems Feasible in Dementia
A holistic exercise program seems feasible and acceptable for people with dementia, according to a feasibility study published online April 25 in the Journal of Bodywork and Movement Therapies.
Unique Brain Patterns Spotted in Children with Comorbid ADHD and Epilepsy
A recent study has discovered that children with both ADHD and recent-onset epilepsy display a unique brain morphology compared to healthy patients.
Electronic Health Records Can Be Used to Boost Practice Revenue
Practices can achieve return on investment for implementation of electronic health record systems if they participate in alternative delivery models, according to an article published May 8 in Medical Economics.
Post-chemotherapy Cognitive Complaints Tied to Brain Activity Changes
For patients undergoing chemotherapy for breast cancer, cognitive complaints after treatment may be associated with changes in brain activity, according to a study published online May 27 in the Journal of Clinical Oncology.
MS Drug Shows Promise in Animal Study for Treatment of PTSD
A new study in mice of the multiple sclerosis drug fingolimod (Gilenya) suggests the drug may be a new therapeutic target for a treatment of post-traumatic stress and other anxiety disorders.
Increased Cognitive Risks in Children with Cochlear Implants
Profoundly deaf children who receive cochlear implants had up to 5 times the risk of delays in areas of working memory, controlled attention, planning, and conceptual learning as children with normal hearing.
Prion-like Protein Linked to Neurodegenerative Disorders
The behavior of a particular prion-like protein is associated with Alzheimer’s disease (AD) and several other neurodegenerative disorders.
Lack of Data Plagues Physician Re-entry Into Practice
There are significant barriers for physicians wishing to re-enter practice following a temporary leave and there are not many available resources to aid in the transition, according to the American Medical Association.
What is the Most Effective Treatment Strategy for Patients with Secondary Progressive Multiple Sclerosis?
Experts examine conflicting evidence regarding the continuation of disease-modifying therapy in patients with secondary progressive multiple sclerosis.
Alemtuzumab: Do the Benefits Outweigh the Risks in Treating Multiple Sclerosis?
Session at the 2014 Annual Meeting of the Consortium of Multiple Sclerosis Centers debates whether the side effects associated with alemtuzumab, a novel anti-CD52 monoclonal antibody, might ultimately prevent its approval for the treatment of multiple sclerosis, despite evidence of clinical effectiveness.
American Academy of Neurology 2013 Annual Meeting
PAINWeek 2013
64th American Academy of Neurology Annual Meeting
2012 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC)
The 63rd Annual Meeting of the American Academy of Neurology
PAINWeek 2010
American Academy of Neurology 2009
International Conference on Alzheimer's Disease 2009
American Epilepsy Society 2008
Condition Centers